EB 003 - Enveric Biosciences
Alternative Names: EB-003 - Enveric BiosciencesLatest Information Update: 30 Jun 2025
At a glance
- Originator Enveric Biosciences
- Class Antidepressants; Anxiolytics; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor modulators; Serotonin 5-HT2A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Anxiety disorders; Depressive disorders
Most Recent Events
- 25 Jun 2025 Pharmacokinetics data from a preclinical study in depressive disorder released by Enveric Biosciences
- 28 May 2025 Pharmacodynamics data from a preclinical study in depressive disorder released by Enveric Biosciences
- 14 May 2025 Enveric Biosciences announces intention to submit an Investigational New Drug Application (IND) for Anxiety disorders and Depressive disorders to the FDA in Q1 2026